Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kestra Med Technologies Ltd. SHS | 0 | 1,795,893 | +1,795,893 | 0 | 44,754 | 26.41% | +44,754 |
| Beta Bionics Inc.(BBNX) | 0 | 1,988,287 | +1,988,287 | 0 | 24,337 | 14.36% | +24,337 |
| Immunic Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | 1,788 | 1,949 | 1.15% | +161 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 1,375 | 1,418 | 0.84% | +42 |
| Syros Pharmaceuticals | 251,270 | 0 | -251,270 | 58 | 0 | — | -58 |
| enGene Holdings Inc. *W EXP 10/31/202 | 321,502 | 321,502 | 0 | 271 | 193 | 0.11% | -78 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 3,689 | 2,879 | 1.70% | -810 |
| Alumis Inc. | 653,223 | 653,223 | 0 | 5,134 | 4,011 | 2.37% | -1,124 |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | 3,500 | 2,358 | 1.39% | -1,142 |
| Lexeo Therapeutics(LXEO) | 1,184,636 | 1,184,636 | 0 | 7,795 | 4,111 | 2.43% | -3,684 |
| Replimune Group(REPL) | 1,975,203 | 1,975,203 | 0 | 23,920 | 19,258 | 11.36% | -4,661 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 38,405 | 28,727 | 16.95% | -9,678 |
| Nuvation Bio(NUVB) | 13,072,340 | 13,072,340 | 0 | 34,772 | 23,007 | 13.58% | -11,765 |
| Upstream Bio Inc.(UPB) | 2,036,293 | 2,036,293 | 0 | 33,477 | 12,462 | 7.35% | -21,015 |